Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Friday 17 July, 2015

AstraZeneca PLC

Holding(s) in Company

RNS Number : 3673T
AstraZeneca PLC
17 July 2015
 



 


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

AstraZeneca PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):


3. Full name of person(s) subject to the
notification obligation:
iii

The Capital Group Companies, Inc.

4. Full name of shareholder(s)
 (if different from 3.):iv

See Schedule A

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

15 July 2015

6. Date on which issuer notified:

16 July 2015

7. Threshold(s) that is/are crossed or
reached:
vi, vii

Above 3%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary

(GB0009895292)

30,372,883

30,372,883



30,472,596


2.4115%


ADRs

(us0463531089)

7,452,630

7,452,630



7,453,217


0.5898%


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

n/a






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

n/a




 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,925,813

3.0013%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

See Schedule A


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:


15. Contact telephone number:



 

 

 

Schedule A

As of 15 July 2015

 

AstraZeneca PLC

 


Number of Shares

Percent of Outstanding




The Capital Group Companies, Inc. ("CG") holdings

37,925,813

3.001%

Holdings by CG Management Companies and Funds:



Capital Guardian Trust Company

5,587,791

0.442%

Capital International Limited

171,800

0.014%

Capital International Sàrl

158,992

0.013%

Capital International, Inc.

72,900

0.006%

Capital Research and Management Company

31,934,330

2.527%

 


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGCGDRGBBBGUR

a d v e r t i s e m e n t